Literature DB >> 7523687

Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside.

S H Yim1, R G Farrer, J A Hammer, E Yavin, R H Quarles.   

Abstract

Cultures consisting primarily of O-2A progenitor cells and immature oligodendrocytes with a few microglia and astrocytes were obtained by shaking primary cultures from neonatal rat brain after 12-14 days in vitro. Addition of 50 micrograms/ml exogenous Neu-NAc alpha 2-3Gal beta 1-4Glc beta 1-1'ceramide (GM3 ganglioside) to the cultures resulted in an increase in the number and thickness of cell processes that stained intensely for sulfatide and galactocerebroside (galC) in comparison to control cultures without added GM3. The treated cultures also contained fewer astrocytes than control cultures as revealed by immunostaining for glial fibrillary acidic protein (GFAP). Cells that immunostained for both GFAP and sulfatide/galC were very rare in control cultures but were frequently seen in the GM3-treated cultures, suggesting that these may represent cells changing their direction of differentiation away from type II astrocytes toward oligodendrocytes under the influence of GM3. These effects on the developing rat oligodendrocytes were specific for GM3 ganglioside and were not produced by adding GM1, GM2, GD3, or GD1a to the cultures. Lactosyl ceramide and neuraminyl lactose were also ineffective. When control cultures were initially plated on polylysine and incubated with [14C]galactose, GD3 was the principal labeled ganglioside. However, as the control cells differentiated over time in culture without the addition of exogenous GM3 and produced increasing amounts of myelin-related components, the incorporation of [14C]galactose into endogenous GM3 increased to become the predominant labeled ganglioside by 6 days after plating. Metabolic labeling of the GM3-treated oligodendrocytes with [14C]galactose revealed increased incorporation into galC and sulfatide in comparison to control cultures, but a decreased labeling of endogenous GM3. Similarly, incorporation of an amino acid precursor into the myelin-associated glycoprotein (MAG) was increased by GM3 treatment, but incorporation into myelin basic protein (MBP) was not affected. Although the overall effect of added GM3 was to decrease the phosphorylation of most proteins in the oligodendrocytes, including MBP, GM3 enhanced the phosphorylation of MAG. These findings indicate that GM3 ganglioside has an important role in the differentiation of cells of the O-2A lineage toward myelin production, since differentiation is associated with increased metabolic labeling of endogenous GM3 in control cultures and is enhanced by the addition of exogenous GM3.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523687     DOI: 10.1002/jnr.490380305

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

1.  Temporal and quantitative expression of the myelin-associated lipids, ethanolamine plasmalogen, galactocerebroside, and sulfatide, in the differentiating CG-4 glial cell line.

Authors:  E Bichenkov; J S Ellingson
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation.

Authors:  G Zeng; T Ariga; X B Gu; R K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

3.  Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.

Authors:  James C Dodge; Christopher M Treleaven; Joshua Pacheco; Samantha Cooper; Channa Bao; Marissa Abraham; Mandy Cromwell; S Pablo Sardi; Wei-Lien Chuang; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

4.  Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice.

Authors:  T Uschkureit; O Sporkel; J Stracke; H Bussow; W Stoffel
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

5.  Negative regulation of oligodendrocyte differentiation by galactosphingolipids.

Authors:  R Bansal; S Winkler; S Bheddah
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

6.  Ganglioside GM3 inhibits proliferation and invasion of glioma.

Authors:  Yasunori Fujimoto; Shuichi Izumoto; Tsuyoshi Suzuki; Manabu Kinoshita; Naoki Kagawa; Kouichi Wada; Naoya Hashimoto; Motohiko Maruno; Yuji Nakatsuji; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

Review 7.  Oligodendrocyte development and myelin biogenesis: parsing out the roles of glycosphingolipids.

Authors:  Nicole Jackman; Akihiro Ishii; Rashmi Bansal
Journal:  Physiology (Bethesda)       Date:  2009-10

8.  Comparison of the phosphorylation of myelin-associated glycoprotein in cultured oligodendrocytes and Schwann cells.

Authors:  S H Yim; K Toda; S Goda; R H Quarles
Journal:  J Mol Neurosci       Date:  1995       Impact factor: 3.444

Review 9.  Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis.

Authors:  Judith M Greer
Journal:  Mult Scler Int       Date:  2013-11-07

Review 10.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.